HomeFDMT • NASDAQ
add
4D Molecular Therapeutics Inc
Previous close
$26.38
Day range
$26.17 - $27.84
Year range
$9.44 - $36.25
Market cap
1.35B USD
Avg Volume
603.62K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | -19.00K | -101.52% |
Operating expense | 97.96M | 23.22% |
Net income | -32.28M | -17.91% |
Net profit margin | 169.91K | 7,838.72% |
Earnings per share | -0.77 | 8.33% |
EBITDA | -35.55M | -28.31% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 288.23M | 34.97% |
Total assets | 339.89M | 29.81% |
Total liabilities | 32.06M | 5.09% |
Total equity | 307.83M | — |
Shares outstanding | 49.78M | — |
Price to book | 3.69 | — |
Return on assets | -26.12% | — |
Return on capital | -27.45% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -32.28M | -17.91% |
Cash from operations | -24.65M | -10.97% |
Cash from investing | -6.68M | 81.32% |
Cash from financing | 4.76M | 132.75% |
Net change in cash | -26.57M | 52.51% |
Free cash flow | -15.02M | -12.62% |
About
Founded
2013
Headquarters
Website
Employees
147